Ferumoxtran-10, A Superparamagnetic Iron Oxide as a Magnetic Resonance Enhancement Agent for Imaging Lymph Nodes: A Phase 2 Dose Study

References

1. ↵
   Jung CW. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995;13 ;675–691

   CrossRefPubMedWeb of Science
2. ↵
   Jung CW, Jacobs P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging 1995;13:661–674

   CrossRefPubMedWeb of Science
3. ↵
   Anzai Y, Prince MR. Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in head and neck cancer. J Magn Reson Imaging 1997;7:75–81

   PubMed
4. ↵
   Anzai Y, McLachlan S, Morris M, et al. Dextran-coated superparamagnetic iron oxide: An MR contrast agent for assessing lymph nodes in the head and neck. AJNR Am J Neuroradiol 1994;15:87–94

   Abstract/FREE Full Text
5. ↵
   Vassallo P, Matei C, Heston WDW, et al. AMI-227-enhanced MR lymphography: Usefulness for differentiating reactive from tumor-bearing lymph nodes. Radiology 1994;193:501–506

   PubMedWeb of Science
6. ↵
   McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994;301–307
7. ↵
   Batsakis JG. Tumors of the head and neck: clinical and pathological considerations. 2nd ed. Baltimore, Md: Williams & Wilkins;1979 :240–251
8. ↵
   Van den Brekel MWM, Stel HV, Castelijns JA, et al. Cervical lymph node metastases: assessment of radiological criteria. Radiology 1990;177:379–384

   PubMedWeb of Science
9. ↵
   Close JG, Merkel M, Vuitch MF, et al. Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx. Head Neck 1989;11:309–317

   PubMedWeb of Science
10. ↵
    Don DM, Anzai Y, Lufkin RB, et al. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995;105:669–674

    PubMedWeb of Science
11. ↵
    Herrera-Ornales L, Justiniano J, Castillo N, et al. Metastases in small lymph nodes from colon cancer. Arch Surg 1987;122:1253–1256

    CrossRefPubMedWeb of Science
12. ↵
    Yousem D, Som PM, Hackney DB, et al. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992;182:753–759

    PubMedWeb of Science
13. ↵
    Dooms GC, Hricak H, Crooks LE, et al. Magnetic resonance imaging of the lymph nodes: comparison with CT. Radiology 1984;153:719–728

    PubMedWeb of Science
14. Dooms GC, Hricak H, Moseley MR, et al. Characterization of lymphadenopathy by magnetic relaxation times: preliminary results. Radiology 1985;155:691–697

    PubMed
15. Glazer G, Orringer M, Chenevert T, et al. Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. Radiology 1988;168:429–431

    PubMed
16. ↵
    Lee J, Heiken J, Ling D, et al. Magnetic resonance imaging of abdominal and pelvic lymphadenopathy. Radiology 1984;153:181–188

    PubMedWeb of Science
17. ↵
    Anzai Y, Blackwell KE, Hirschowitz SL, et al. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994;192:709–715

    PubMedWeb of Science
18. ↵
    Lee AS, Weissleder R, Brady TJ, et al. Lymph nodes: microstructural anatomy at MR imaging. Radiology 1991;178:519–522

    PubMedWeb of Science